Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 3, 1999

View Archived Issues

BioChem Pharma: five-year growth prospects

Development highlights at Transkaryotic Therapies during Q3 1999

Biovail discusses proprietary pipeline at investor conference

Rigel and Novartis enter collaboration to discover B-cell mediators

Angiotech updates paclitaxel clinical trial development

New therapeutic agents for heart failure: heart rate-lowering chromanes

Semisynthetic ecteinascidins presented in recent patent issued to U. of Illinois

Shionogi describes wide series of sPLA2 inhibitors

FDA approves IND for North American Vaccine's Hib vaccine

CRF antagonists under study at DuPont for anxiety, depression, etc.

SB and NPS disclose calcilytics arising from joint research program; collaboration continues

Maxamine in combination with IL-2 shows positive results in brain cancer model

Relpax is approvable, FDA says

NewBiotics enters agreement with Ilex for colon cancer therapy

New cyclin-dependent kinase inhibitors in the Boehringer Ingelheim pipeline

Grant will fund development and clinical testing of new vaginal microbicide from Population Council

FDA advisory committee does not recommend approval of adefovir dipivoxil

Rock/Rho kinase inhibitor Y-27632: a promising vasodilator for treatment of heart failure

FDA requests further data to support frovatriptan NDA

MCC-135 restores impaired Ca2+-ATPase activity in the postischemic myocardium

Prototype blood clot imaging agent presented this week by Epix

Avanir reports positive developments in docosanol approval process

Angiomax available through expanded access study in HIT/HITTS patients

Prucalopride dramatically improves symptoms in patients with chronic constipation

Combination of FTY-720 and ciclosporin inhibits pig islet xenograft rejection in rats

CA-074: a cathepsin B inhibitor with potential in xenotransplantation

Potential new approach to xenotransplantation: WF-10-containing combinations

News from ET-6: selective endothelin ETA antagonists from Knoll/BASF

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...